These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37315918)

  • 21. Somatic CAG Repeat Stability in a Transgenic Sheep Model of Huntington's Disease.
    Handley RR; Reid SJ; Burch Z; Jacobsen JC; Gillis T; Correia K; Rudiger SR; McLaughlin CJ; Bawden CS; MacDonald ME; Wheeler VC; Snell RG
    J Huntingtons Dis; 2024; 13(1):33-40. PubMed ID: 38393920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Huntington's and myotonic dystrophy hESCs: down-regulated trinucleotide repeat instability and mismatch repair machinery expression upon differentiation.
    Seriola A; Spits C; Simard JP; Hilven P; Haentjens P; Pearson CE; Sermon K
    Hum Mol Genet; 2011 Jan; 20(1):176-85. PubMed ID: 20935170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of the Huntington's disease CAG mutation in striatum and cerebellum are quantitative not qualitative.
    Fossale E; Seong IS; Coser KR; Shioda T; Kohane IS; Wheeler VC; Gusella JF; MacDonald ME; Lee JM
    Hum Mol Genet; 2011 Nov; 20(21):4258-67. PubMed ID: 21840924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Contributors to Intergenerational CAG Repeat Instability in Huntington's Disease Knock-In Mice.
    Neto JL; Lee JM; Afridi A; Gillis T; Guide JR; Dempsey S; Lager B; Alonso I; Wheeler VC; Pinto RM
    Genetics; 2017 Feb; 205(2):503-516. PubMed ID: 27913616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression levels of DNA replication and repair genes predict regional somatic repeat instability in the brain but are not altered by polyglutamine disease protein expression or age.
    Mason AG; Tomé S; Simard JP; Libby RT; Bammler TK; Beyer RP; Morton AJ; Pearson CE; La Spada AR
    Hum Mol Genet; 2014 Mar; 23(6):1606-18. PubMed ID: 24191263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington disease.
    Ferguson R; Goold R; Coupland L; Flower M; Tabrizi SJ
    Am J Hum Genet; 2024 Jun; 111(6):1165-1183. PubMed ID: 38749429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA Mismatch Repair and its Role in Huntington's Disease.
    Iyer RR; Pluciennik A
    J Huntingtons Dis; 2021; 10(1):75-94. PubMed ID: 33579865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CAG Somatic Instability in a Huntington Disease Expansion Carrier Presenting with a Progressive Supranuclear Palsy-like Phenotype.
    Dewan R; Jaunmuktane Z; Garcia-Segura ME; Strand C; Wild E; Villar J; Dalgard CL; Tabrizi SJ; Traynor BJ; Proukakis C
    Mov Disord; 2022 Jul; 37(7):1555-1557. PubMed ID: 35510647
    [No Abstract]   [Full Text] [Related]  

  • 30. Msh3 and Pms1 Set Neuronal CAG-repeat Migration Rate to Drive Selective Striatal and Cortical Pathogenesis in HD Mice.
    Wang N; Zhang S; Langfelder P; Ramanathan L; Plascencia M; Gao F; Vaca R; Gu X; Deng L; Dionisio LE; Prasad BC; Vogt T; Horvath S; Aaronson JS; Rosinski J; Yang XW
    bioRxiv; 2024 Jul; ():. PubMed ID: 39026894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.
    Cummings DM; Alaghband Y; Hickey MA; Joshi PR; Hong SC; Zhu C; Ando TK; André VM; Cepeda C; Watson JB; Levine MS
    J Neurophysiol; 2012 Jan; 107(2):677-91. PubMed ID: 22072510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
    Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
    Ann Neurol; 2001 Dec; 50(6):373-80. PubMed ID: 11761463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
    Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
    Ann Neurol; 2001 Sep; 50(3):373-80. PubMed ID: 11558794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes.
    Ciosi M; Maxwell A; Cumming SA; Hensman Moss DJ; Alshammari AM; Flower MD; Durr A; Leavitt BR; Roos RAC; ; ; Holmans P; Jones L; Langbehn DR; Kwak S; Tabrizi SJ; Monckton DG
    EBioMedicine; 2019 Oct; 48():568-580. PubMed ID: 31607598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-dependent reduction of somatic expansions but not Htt aggregates by di-valent siRNA-mediated silencing of MSH3 in HdhQ111 mice.
    Driscoll R; Hampton L; Abraham NA; Larigan JD; Joseph NF; Hernandez-Vega JC; Geisler S; Yang FC; Deninger M; Tran DT; Khatri N; Godinho BMDC; Kinberger GA; Montagna DR; Hirst WD; Guardado CL; Glajch KE; Arnold HM; Gallant-Behm CL; Weihofen A
    Sci Rep; 2024 Jan; 14(1):2061. PubMed ID: 38267530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington's disease.
    Choi DE; Shin JW; Zeng S; Hong EP; Jang JH; Loupe JM; Wheeler VC; Stutzman HE; Kleinstiver B; Lee JM
    Elife; 2024 Jun; 12():. PubMed ID: 38869243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FAN1 modifies Huntington's disease progression by stabilizing the expanded HTT CAG repeat.
    Goold R; Flower M; Moss DH; Medway C; Wood-Kaczmar A; Andre R; Farshim P; Bates GP; Holmans P; Jones L; Tabrizi SJ
    Hum Mol Genet; 2019 Feb; 28(4):650-661. PubMed ID: 30358836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous and periodic expansion of CAG repeats in Huntington's disease R6/1 mice.
    Møllersen L; Rowe AD; Larsen E; Rognes T; Klungland A
    PLoS Genet; 2010 Dec; 6(12):e1001242. PubMed ID: 21170307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Verification of somatic CAG repeat expansion by pre-PCR fractionation.
    Hunter JM; Crouse AB; Lesort M; Johnson GV; Detloff PJ
    J Neurosci Methods; 2005 May; 144(1):11-7. PubMed ID: 15848234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Length-dependent CTG·CAG triplet-repeat expansion in myotonic dystrophy patient-derived induced pluripotent stem cells.
    Du J; Campau E; Soragni E; Jespersen C; Gottesfeld JM
    Hum Mol Genet; 2013 Dec; 22(25):5276-87. PubMed ID: 23933738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.